Chiral design
US12180472B2 · kind B2 · utility
0Cited by
15References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2020 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | May 30, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.